Annovis Bio Enhances Leadership Team with Two Senior Appointments
Company Appoints Eve Damiano, MS, RAC, as Senior Vice President of Regulatory Operations
Company Promotes Cheng Fang, Ph.D., to Senior Vice President of Research & Development
Annovis Bio Enhances Leadership Team with Two Senior Appointments
Company Appoints Eve Damiano, MS, RAC, as Senior Vice President of Regulatory Operations
Company Promotes Cheng Fang, Ph.D., to Senior Vice President of Research & Development
VESTECK named “Top 10 Cardiovascular Device Company for 2021” by MedTech Outlook Magazine
Relmada Therapeutics Announces Publication of REL-1017 Phase 2 Study Results in The American Journal of Psychiatry
– Manuscript further details findings from study assessing REL-1017 as adjunctive treatment for MDD
– Primary endpoint results included rapid, significant, and sustained efficacy vs. placebo
– Safety analysis showed adverse event profile comparable to placebo, with no signs or symptoms of withdrawal or psychotomimetic effects associated with NMDAR blocking
Annovis Bio Announces Publication of ANVS401 Mechanism of Action in Peer-Reviewed Pharmaceutics
ANVS401 (Posiphen) Inhibits the Translation of mRNAs of Neurotoxic Proteins Responsible for the Progression of Neurodegenerative Diseases
ImmunoGenesis Appoints Oncology Research Veteran to Lead Immuno-Oncology Clinical Development Targeting Immune-Excluded, “Cold” Cancers
Clinical trials for ImmunoGenesis drug candidates to initiate in 2022
Relmada Therapeutics Announces Closing of Public Offering and Full Exercise of Over-Allotment Option
AllianceChicago to Offer Wellsheet’s Predictive Clinical Workflow Platform Integrated with athenahealth’s EHR
Wellsheet Integration with athenaOne to Empower Primary Care Clinicians in Community Health Centers